Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
This study is currently recruiting participants.
Verified December 2012 by Threshold Pharmaceuticals
Sponsor:
Threshold Pharmaceuticals
Information provided by (Responsible Party):
Threshold Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01149915
First received: June 1, 2010
Last updated: December 5, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |